Combination chemotherapy of Hodgkin's disease.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use*; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000401:mortality / Q000532:radiotherapy; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*; D011239:Prednisolone / Q000627:therapeutic use*; D014747:Vinblastine / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D001565:Benzoates; D006834:Hydrazines; D009588:Nitrogen Mustard Compounds; D014747:Vinblastine; D011239:Prednisolone